Additional Information

Product Description

MONOVISC 22 MG/ML PFS 4ML is a sterile, clear, and viscous solution used to treat knee pain caused by osteoarthritis. The product is intended for use by healthcare professionals only and is not available for self-administration.

The main active ingredient in MONOVISC 22 MG/ML PFS 4ML is hyaluronan, which is a naturally occurring substance found in the synovial fluid of joints. The solution is designed to mimic the natural properties of synovial fluid and provide cushioning and lubrication to the knee joint, reducing pain and improving mobility.

Each pre-filled syringe of MONOVISC 22 MG/ML PFS 4ML contains 4 milliliters of hyaluronan at a concentration of 22 milligrams per milliliter. The solution is injected directly into the knee joint by a healthcare professional. The recommended dose is a single injection.

MONOVISC 22 MG/ML PFS 4ML has been extensively studied and shown to be a safe and effective treatment for knee pain caused by osteoarthritis. The product has a high degree of tolerability, with few adverse effects. Some common side effects may include mild pain or swelling at the injection site, which usually resolves on its own within a few days. The duration of pain relief provided by MONOVISC 22 MG/ML PFS 4ML varies among patients but can last up to six months.

In summary, MONOVISC 22 MG/ML PFS 4ML is an effective treatment option for patients suffering from knee pain caused by osteoarthritis. It provides significant pain relief and improves joint function, helping to restore mobility and quality of life.